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Volume 58, Number 3 Abstracts 849for CMI were 1.8/2.0/2.1% for OR, 7.1/9.5/9.8% for repeat PTA/S, and
6.6/7.8/8.4% for readmission without repair. During the index admission,
mortality after OR was higher than PTA/S for both AMI (35% vs 19%; P <
.001) and CMI (10% vs 2%; P < .001). Three deaths occurred during
a revisit: two after OR, one after PTA/S; all three for CMI. When revisits
were excluded, the rise in PTA/S procedures persisted for CMI (Fig).
Conclusions: Revisits after mesenteric revascularization are most
frequent after PTA/S for CMI. After excluding reinterventions, numbers
of PTA/S are still increasing, so the rise in PTA/S is attributable mostly
to treatment of new patients. PTA/S is increasingly being performed in
the outpatient setting.Fig 1. Remodeling of the stented aortic segment over time. SFL, Stented
false lumen; SMAX, maximum stented diameter; STL, stented true
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Objectives: The application of thoracic endovascular aortic repair
(TEVAR) has changed treatment paradigms for thoracic aortic disease.
We sought to better deﬁne speciﬁc treatment patterns and outcomes for
Type B aortic dissection treated with TEVAR or open surgical repair
(OSR).
Methods: Medicare patients undergoing thoracic aortic dissection
repair (2000-2010) were identiﬁed using a validated International Classiﬁ-
cation of Diseases-Ninth Revision diagnostic and procedural code-based
algorithm. Trends in utilization were analyzed by procedure type (OSR vs
TEVAR), and secular patterns in patient characteristics and outcomes
were examined.
Results: Total thoracic aortic dissection repairs increased by 21%
between 2000 and 2010 (2.5 to 3 per 100,000 Medicare patients; P <
.001; Fig). A concomitant increase in TEVAR was seen during the same
interval (0.03 to 0.8 per 100,000; P < .001). By 2010, TEVAR comprised
27% of all repairs. TEVAR patients had higher rates of comorbid congestive
heart failure (P < .001), chronic obstructive pulmonary disease (P < .001),
diabetes (P < .001), and chronic renal failure (P < .001) when compared
with OSR. For all repairs, patient comorbidity burden increased over time
(proportion of patients with Charlson comorbidity score greater than 2: 13%
in 2000, 18% in 2010; P < .001). During this same interval, in-hospital
mortality rates declined from 47% to 23% (P < .001). While in-hospital
mortality rates and 3-year survival were similar between patients selected for
TEVAR and OSR, women had slightly lower 3-year survival following
TEVAR (60% women vs 63% men; P ¼ .05).
Conclusions: Surgical treatment of type B aortic dissection has
increased over time, reﬂecting an increase in the utilization of TEVAR,
and is currently performed in sicker patients with better outcomes. While
perioperative mortality has improved for both OSR and TEVAR, slightly
worse survival for women with TEVAR requires further investigation.Fig.Late Aortic Remodeling Persists in the Stented Segment After
Endovascular Repair of Acute Complicated Type B Aortic Dissection
Mark F. Conrad, Christopher J. Kwolek, Shankha Mukhopadhyay, Virendra
I. Patel, Richard P. Cambria. Massachusetts General Hospital, Boston, MassObjectives: Thoracic endovascular aortic repair (TEVAR) for acute
complicated type B dissection (cTBD) promotes early positive aortic remod-
eling. However, little is known about the long-term effect of TEVAR on the
dissected aorta, which is the goal of this study.
Methods: Between August 2005 and August 2009, 31 patients with
cTBD were treated with TEVAR and had long-term (>1 year) follow-up
imaging. CTA obtained at 1 month (1M), 1 year (1Y), and long-term
(LT; average 42 months) were compared with baseline (BL) scans. The
largest diameters of the stented thoracic aorta (SMAX), stented true lumen
(STL), and stented false lumen (SFL) were recorded at each time point, as
were the values in the unstented distal thoracic aorta and the abdominal
aorta. Changes over time were evaluated using a mixed effect analysis of
variance model of repeated measures.
Results: Demographics: age 56 years; 74% male. Indications for
TEVAR: 61% malperfusion, 32% refractory hypertension, 45% impending
rupture, 32% persistent pain; 58% had >one indication. The average length
of aorta covered was 19 cm. Aortic remodeling along the stented segment is
summarized in Fig 1. The SMAX remained stable (P ¼ not signiﬁcant), STL
increased (P < .001), and SFL decreased (P < .001) over time; 84% had
complete false lumen (FL) obliteration. For the uncovered segment, the
maximum diameter increased (P ¼ .014), as did TL (P < .001) and the
visceral segment (P < .001). The FL was stable (P ¼ not signiﬁcant). Theaverage growth of the visceral segment was 31% in patients with a patent FL
vs 3% in those without (P ¼ .004). One patient had aneurysmal degener-
ation of the false lumen and required an additional endograft at 2 years.
Conclusions: TEVAR of cTBD promotes long-term remodeling
across the stented segment with FL obliteration in 84% of patients.
However, FL obliteration beyond the stented segment appears necessary
to prevent late aneurysmal degeneration.Results of Transcaval Embolization for Sac Expansion from Type II
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Objectives: The increase of endovascular aortic repair (EVAR) has
been accompanied by a consequent increase in Type II endoleaks. This
study reports our experience with transcaval coil embolization (TCCE),
a novel strategy to treat this complication.
Methods: We reviewed 24 consecutive patients undergoing TCCE
from 2010 to 2013. Demographics, operative details, and outcomes were
assessed.
Results: Since 2006, over 450 EVARs have been performed at our
institution with 24 TCCE performed in 22 patients for sac expansion
from Type II endoleaks. Patients were male (87%) former or current
smokers (87%) with an average age of 78 (67.2) years. TCCE was per-
formed a mean of 4.2 (64) years after initial EVAR (21% for rupture).
Endoleaks resulted in a mean sac growth of 1.2 (60.9) cm diameter and
38% 6 35% volume. Forty-two percent had failed prior procedures (ﬁve
translumbar, two transcaval, two aortic cuff, two internal iliac branch embo-
lization, and one fenestrated branched endograft). Two patients had ulti-
mate sac access between the endograft iliac limb and arterial wall after
transcaval puncture failed with an overall 87% technical success (79% for
